News
7x24
Quotes
Economic Calendar
Video
Data
- Names
- Latest
- Prev.
[Waters Corp. Sees Increased Demand In India For GLP-1 Drug Testing Equipment] U.s.-based Waters Corp, A Maker Of Medical Testing Equipment, Is Experiencing Increased Demand From Indian Drugmakers Racing To Develop Generic Versions Of Popular GLP-1 Weight-loss Drugs Like Semaglutide Ahead Of The Patent Expiry In India In 2026. With Local Drugmakers Including Biocon, Cipla, Dr. Reddy's And Lupin Actively Developing These Generics For The Potentially $150 Billion Global Market, Waters' India Unit, Which Contributes About 8% To Its Global Sales, Anticipates Double-digit Revenue Growth Percentage In India And Expects Specific Basis Point Contributions From Its Overall India Business And GLP-1 Testing Demand.
Quick Access to 7x24
Quick Access to More Editor-selected Real-time News
Exclusive video for free
FastBull project team is dedicated to create exclusive videos
Real-time Quotes
View more faster market quotes
More comprehensive macro data and economic indicators
Members have access to entire historical data, guests can only view the last 4 years
Member-only Database
Comprehensive forex, commodity, and equity market data